Yelda Ulu Colin – Managing Director Turkey, Iran, Azerbaijan, Georgia, Lebanon, N. Cyprus, Abbott Core Diagnostics

General manager of Core Diagnostic at Abbott Turkey Yelda Ulu Colin highlights the company's prominent role during the pandemic, including the launch of the first antibody serology testing solution just one month after the World Health Organization made an official pandemic declaration. In addition, she categorizes the government’s response to the emergency as “efficient” and tackles the question of workforce diversity in Turkey.  
As a company, we were fortunate to be able to provide advanced healthcare IT systems [during the COVID-19 pandemic] that provided process optimization for users, helping manage testing more efficiently both in the private and public sectors
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report